NASDAQ:STDY
Delisted

SteadyMed Ltd. Fund Signals

$4.73
+0 (+0%)
At Close: Sep 18, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 1.260 1 day ( 0 % )
Last Price $4.73 0 %
High/ Low $4.73 - $4.73 0%
Chg 7 Days N/A $4.73 $4.73
Chg 30 Days 1.61 % $4.65 $4.73
Chg 12 mos 41.04 % $3.35 $4.73
Trend - 3 mos 5.09 % Width: 4.69 %
Trend - 12 mos 55.55 % Width: 59.74 %
Pred. range - 3 mos $4.91 - $5.14 3.84 % - 8.72 %
Pred. range - 12 mos $5.37 - $8.57 13.58 % - 81.43 %
Short MA avg 3 mos Sell Sep 04, 2018 - 11 days
Long MA avg 3 mos Sell Aug 22, 2018 - 19 days
Short/Long MA avg 3 mos Buy Jul 24, 2018 - 40 days
Short MA avg 12 mos Sell Sep 11, 2018 - 6 days
Long MA avg 12 mos Buy Apr 27, 2018 - 100 days
Short/Long MA avg 12 mos Buy May 02, 2018 - 97 days
Pivot Short Sell Aug 28, 2018 - 15 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About SteadyMed Ltd.

SteadyMed Ltd., together with its subsidiaries, operates as a specialty pharmaceutical company that focuses on the development and commercialization of drug product candidates for the treatment of orphan and other diseases with unmet parenteral delivery needs. It engages in developing Trevyent for the treatment of pulmonary arterial hypertension. The company also develops two products for the treatment of post-surgical and acute pain in the home ... STDY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT